Skip to main content
Scroll Top
Menu
WHO WE ARE
ABOUT US
TEAM
MANAGEMENT TEAM
INDUSTRIAL ADVISORS
SCIENTIFIC COUNCIL
PARTNERS
R&D
INTRODUCTION
TECH
NEUROSTIMULATION
PHOTOBIOMODULATION
ALZHEIMER
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
CONCUSSION
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
SOLUTIONS
CLINICAL RESEARCH
PRECLINICAL RESEARCH
CONCUSSION
NEWS
ALL
PRESS ARTICLES
VIDEOS
EVENTS
SCIENTIFIC PUBLICATIONS
ALL
SCIENTIFIC ARTICLES
ORAL COMMUNICATIONS
POSTED COMMUNICATIONS
CONTACT
FAQ
Executive summary
Français
Menu
WHO WE ARE
ABOUT US
TEAM
MANAGEMENT TEAM
INDUSTRIAL ADVISORS
SCIENTIFIC COUNCIL
PARTNERS
R&D
INTRODUCTION
TECH
NEUROSTIMULATION
PHOTOBIOMODULATION
ALZHEIMER
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
CONCUSSION
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
SOLUTIONS
CLINICAL RESEARCH
PRECLINICAL RESEARCH
CONCUSSION
NEWS
ALL
PRESS ARTICLES
VIDEOS
EVENTS
SCIENTIFIC PUBLICATIONS
ALL
SCIENTIFIC ARTICLES
ORAL COMMUNICATIONS
POSTED COMMUNICATIONS
CONTACT
FAQ
Executive summary
Français
Home
Alzheimer
Relevance of photobiomodulation technique in AD treatment
Most Viewed Posts
Clear Filters
MedInTechs 2026 – Parc Floral de Paris | 9 & 10 March
20 March 2026
REGEnLIFE attempts to prove that advanced phototherapy can cure Alzheimer’s disease
31 October 2024
REGEnLIFE cures inflammatory brain diseases with light
21 February 2025
5 November 2020
Relevance of photobiomodulation technique in AD treatment
13th Clinical Trials on Alzheimer’s Disease (CTAD) 2020, virtual conference
Read the article
Jacques Touchon
Share this article
alzheimer
Oral Communications
Post navigation
Previous post
The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impacts Gut Microbiota Dysbiosis
Next post
Photobiomodulation at the Level of Single Neural Cells in Culture
Get a Quote
Hidden fields
